OPTIMIERTE POLYNUKLEOTIDE ZUR PROTEINEXPRESSION

Patent europeic · EP4460334 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4460334
Numer da la dumonda
EP23706945
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
06-01-2023
Publitgà
13-11-2024
Concedì
14-10-2026
La protecziun finescha il pli tard
05-01-2043
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61K 48/00 (2006.01)
A61K 31/00 (2006.01)
C12N 15/67 (2006.01)
C12N 15/85 (2006.01)
Prioritad
US 202263297630 P 07.01.2022
Dumonda PCT
PCT/US2023/060258 06.01.2023
Publicaziun PCT
WO2023/133525 13.07.2023
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 14-10-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 14.10.2026

Partidas

Possessur

Precision BioSciences, Inc.

302 East Pettigrew Street Dibrell Building, Suite A-100, Durham, NC 27701, US

Inventur

HARRIS, Jason Richard

Durham, NC 27712, US

HEKELE, Armin

Cary, NC 27519, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.